VINGIANI, ANDREA

VINGIANI, ANDREA  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 20 di 86 (tempo di esecuzione: 0.001 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research 2024 Provenzano, LeonardoMazzeo, LauraSpagnoletti, AndreaGiani, ClaudiaPizzutilo, Elio GregoryLorenzini, DanieleManglaviti, SaraBeninato, TeresaLeporati, RitaAmbrosini, PaoloSerino, RobertaSilvestri, Ceciliade Braud, FilippoPruneri, GiancarloVingiani, Andrea + Article (author) -
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/ metastatic head and neck squamous cell carcinoma treated with nivolumab 2024 Cavalieri S.Licitra L.Vingiani A. + Article (author) -
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer 2023 Vingiani A.Pruneri G. + Article (author) -
Multigene signatures for early breast cancer in clinical practice: A report of the Lombardy genomic assays for breast cancer working group 2023 Vingiani A.Pruneri G.Bianchini G. + Article (author) -
Macrophage morphology and distribution are strong predictors of prognosis in resected colorectal liver metastases: results from an external retrospective observational study 2023 Sposito, CarloMarchesi, FedericaVingiani, AndreaMazzaferro, Vincenzo + Article (author) -
End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO 2023 Vingiani A.Pruneri G. + Article (author) -
Multidisciplinary management of pregnancy-associated and early post-partum head and neck cancer patients 2023 Cavalieri S.Vingiani A.Deganello A.Licitra L. + Article (author) -
Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison 2023 Ligorio F.Rametta A.Leporati R.Depretto C.Vingiani A.Pruneri G.de Braud F. + Article (author) -
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors 2023 Sposetti C.Leporati R.Corti C.Ligorio F.Provenzano L.Vingiani A.Sirico M.Zagami P.Boldrini L.Losurdo A.Criscitiello C.Curigliano G.Pruneri G.de Braud F. + Article (author) -
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC) 2023 Vingiani A.Viale G.Pruneri G. + Article (author) -
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers 2022 Niger, MonicaNichetti, FedericoPircher, ChiaraVingiani, AndreaAgnelli, LucaPusceddu, SaraCorti, FrancescaPrisciandaro, MicheleBini, MartaPruneri, GiancarloMazzaferro, VincenzoPietrantonio, Filippode Braud, Filippo + Article (author) -
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin 2022 Zattarin, EmmaNichetti, FedericoLigorio, FrancescaMazzeo, LauraLobefaro, RiccardoFuca, GiovanniPeverelli, GiorgiaVingiani, Andreade Braud, FilippoVernieri, Claudio + Article (author) -
Mammographic density to predict response to neoadjuvant systemic breast cancer therapy 2022 Depretto, CDe Braud, F GVingiani, APruneri, G + Article (author) -
Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer 2022 Pruneri G.Vingiani A. + Article (author) -
Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples 2022 Capone I.Verderio P.Busico A.Monti V.Duca M.Damian S.Lorenzini D.Vingiani A.Agnelli L.Pruneri G. + Article (author) -
Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer 2022 Curigliano G.Vingiani A. + Article (author) -
Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer 2022 Silvestri M.Dugo M.Lanzoni D.Vingiani A.de Braud F.Pruneri G. + Article (author) -
Acquired Resistance Mechanisms to PD-L1 Blockade in a Patient With Microsatellite Instability-High Extrahepatic Cholangiocarcinoma 2022 Andrea VingianiFilippo PietrantonioFilippo de BraudGiancarlo PruneriVincenzo Mazzaferro + Article (author) -
Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model 2022 Azzollini, JacopoVingiani, AndreaAgnelli, LucaRosina, EricaDucceschi, MonikaNiger, MonicaDamian, Silviade Braud, FilippoPruneri, Giancarlo + Article (author) -
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer 2022 Galli, GiuliaCorsetto, Paola AntoniaBrambilla, MartaOcchipinti, MarioManglaviti, SaraVingiani, AndreaRizzo, Angela Mariade Braud, Filippo + Article (author) -